Phase-1/-2 study of pomalidomide in chronic GvHD.

Pusic, I; Rettig, M P; DiPersio, J F; Bauer, S; McFarland, K; Gale, R P; Pavletic, S Z

Pusic, I; Rettig, M P; DiPersio, J F; Bauer, S; McFarland, K; Gale, R P; Pavletic, S Z.

Afiliación

Pusic I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Rettig MP; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Bauer S; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
McFarland K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Gale RP; Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.
Pavletic SZ; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Bone Marrow Transplant ; 51(4): 612-4, 2016 Apr.

Article en En | MEDLINE | ID: mdl-26657832

Asunto(s)

Enfermedad Injerto contra Huésped/tratamiento farmacológico; Talidomida/análogos & derivados; Adulto; Enfermedad Crónica; Femenino; Humanos; Masculino; Persona de Mediana Edad; Proyectos Piloto; Talidomida/administración & dosificación; Talidomida/efectos adversos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Talidomida / Enfermedad Injerto contra Huésped Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google